[go: up one dir, main page]

CN114853748A - Trifluoromethyl-containing isoxazoline derivative, and preparation method and application thereof - Google Patents

Trifluoromethyl-containing isoxazoline derivative, and preparation method and application thereof Download PDF

Info

Publication number
CN114853748A
CN114853748A CN202210488398.2A CN202210488398A CN114853748A CN 114853748 A CN114853748 A CN 114853748A CN 202210488398 A CN202210488398 A CN 202210488398A CN 114853748 A CN114853748 A CN 114853748A
Authority
CN
China
Prior art keywords
compound
reaction
trifluoromethane
preparation
react
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210488398.2A
Other languages
Chinese (zh)
Inventor
刘根炎
宋璐璐
闫杰桂
林义峰
李文烨
叶子航
罗晓刚
吴风收
巨修练
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Institute of Technology
Original Assignee
Wuhan Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Institute of Technology filed Critical Wuhan Institute of Technology
Priority to CN202210488398.2A priority Critical patent/CN114853748A/en
Publication of CN114853748A publication Critical patent/CN114853748A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00Arthropodicides
    • A01P7/04Insecticides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Agronomy & Crop Science (AREA)
  • Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention relates to a trifluoromethane-containing isoxazoline derivative, a preparation method and application thereof, belonging to the technical field of pesticide chemistry. The chemical structural formula of the trifluoromethane-containing isoxazoline derivative is shown as a general formula I:
Figure DDA0003630191240000011
wherein R is 1a 、R 1b And R 1c Independently represent any one of hydrogen atom and halogen atom, and the halogen atom represents any one of chlorine atom and fluorine atomSeed; a represents any one of pyrrolyl and B, and B represents any one of phenyl, pyridyl and thiazolyl; r 2 Represented by any one of a hydrogen atom and a methyl group; r 3 Is represented by-CH 2 C(O)NHCH 2 CF 3 、‑OCH 3 、‑CH 2 COOCH 3 And 6-chloropyrimidinyl. The invention also relates to a preparation method of the trifluoromethane-containing isoxazoline derivative. The invention also applies the trifluoromethane isoxazoline derivative to the preparation of pesticides.

Description

一种含三氟甲烷异噁唑啉类衍生物、其制备方法和应用A kind of isoxazoline derivative containing trifluoromethane, its preparation method and application

技术领域technical field

本发明涉及农药化学技术领域,尤其涉及一种含三氟甲烷异噁唑啉类衍生物、其制备方法和应用。The invention relates to the technical field of pesticide chemistry, in particular to a trifluoromethane-containing isoxazoline derivative, a preparation method and application thereof.

背景技术Background technique

在农业生产过程中,杀虫剂的使用是必不可少的环节。几十年来,农药为人类食物的工艺和对人类的安全和健康起到了不可磨灭的作用。农药是确保农业稳产、增收不可或缺的生产资料,也是十分重要的战略物资。In the agricultural production process, the use of pesticides is an essential link. For decades, pesticides have played an indelible role in the crafting of human food and in the safety and health of human beings. Pesticide is an indispensable means of production to ensure stable agricultural production and increase income, and it is also a very important strategic material.

杀虫剂是指杀死害虫的一种药剂,如甲虫、苍蝇、蛴螬、鼻虫、跳虫以及近万种其它害虫。Insecticide refers to an agent that kills pests such as beetles, flies, grubs, nose bugs, springtails and nearly ten thousand other pests.

杀虫剂的使用先后经历了几个阶段:最早发现的是天然杀虫剂及无机化合物,但是它们作用单一、用量大、持效期短;有机氯、有机磷和氨基甲酸酯等有机合成杀虫剂,它们的特征是高效高残留或低残留,但是其中有不少杀虫剂品种对哺乳动物有高的急性毒性。The use of pesticides has gone through several stages: the earliest discovered are natural pesticides and inorganic compounds, but they have a single effect, a large amount, and a short duration of effect; organic synthesis of organic chlorine, organic phosphorus and carbamate Insecticides, which are characterized by high efficiency with high residues or low residues, but many of them have high acute toxicity to mammals.

新的杀虫剂,开始使用时,杀虫效果往往很好,但是随着用量不断增加和使用范围不断扩大,抗药性上升的案例不断出现。现有的杀虫剂,例如氯菊酯、氯氰菊酯、高效氯氰菊酯、顺式氯氰菊酯、氟氯氰菊酯、氰戊菊酯、顺式氰戊菊酯和氟氰戊菊酯等,都属于神经毒素类杀虫剂,也属于中等毒性杀虫剂,即通过进食进入到害虫体内破坏神经传导功能,或是接触到害虫身体后,而引起害虫极度兴奋、痉挛、麻痹,最终死亡。然而,自然界害虫种群中搬来存在对杀虫剂敏感程度不同的个体,杀虫剂使用过程中实质上是采用杀虫剂对害虫种群起到选择作用,每次使用,就会留下相对抗药的个体,杀死相对敏感的个体,导致杀虫剂长时间使用或增加用量,使得害虫群体的抗药性水平或多或少的得以提高。New insecticides, when first used, tend to have good insecticidal effects, but as the dosage continues to increase and the scope of use continues to expand, cases of rising drug resistance continue to emerge. Existing pesticides, such as permethrin, cypermethrin, beta-cypermethrin, cis-cypermethrin, cyfluthrin, fenvalerate, cis-fenvalerate and fenvalerate, etc., are all neurotoxin insecticides It is also a medium-toxic insecticide, that is, it enters the body of the pest by eating and destroys the nerve conduction function, or after contacting the body of the pest, it causes the pest to be extremely excited, convulsed, paralyzed, and eventually died. However, there are individuals with different degrees of sensitivity to pesticides in natural pest populations. In the process of pesticide use, pesticides are essentially used to select pest populations. The insecticides kill relatively sensitive individuals, resulting in prolonged use or increased dosage of insecticides, resulting in a more or less increase in the resistance level of the pest population.

现有技术中,在EP1,731,512中披露了某些具有杀昆虫特性的异噁唑啉衍生物,中国专利CN200880103027.6公开了异噁唑啉组合物及其作为抗寄生虫药的用途,然而,上述异噁唑啉衍生物的杀虫剂,害虫已对其产生了抗药性。In the prior art, some isoxazoline derivatives with insecticidal properties are disclosed in EP1,731,512, and Chinese patent CN200880103027.6 discloses isoxazoline compositions and their use as antiparasitic drugs, however , the above-mentioned isoxazoline derivatives of pesticides, pests have developed resistance to them.

鉴于此,有必要提供一种新的杀虫剂。In view of this, it is necessary to provide a new insecticide.

发明内容SUMMARY OF THE INVENTION

本发明为了解决上述技术问题提供一种含三氟甲烷异噁唑啉类衍生物、制备方法和应用。该含三氟甲烷异噁唑啉类衍生物对有害昆虫具有较好的杀虫活性,尤其是对果蝇和玉米螟具有更好的杀虫活性,能够作为杀虫剂及其组合物应用。In order to solve the above technical problems, the present invention provides a trifluoromethane-containing isoxazoline derivative, a preparation method and an application. The trifluoromethane-containing isoxazoline derivatives have better insecticidal activity against harmful insects, especially against fruit flies and corn borers, and can be used as insecticides and compositions thereof.

本发明解决上述技术问题的技术方案如下:The technical scheme that the present invention solves the above-mentioned technical problems is as follows:

一种含三氟甲烷异噁唑啉类衍生物,其化学结构式如通式Ⅰ所示:A kind of isoxazoline derivatives containing trifluoromethane, its chemical structure is shown in general formula I:

Figure BDA0003630191230000021
Figure BDA0003630191230000021

其中,R1a、R1b和R1c彼此独立的表示为氢原子和卤素原子中的任意一种,所述卤素原子表示为氯原子和氟原子中的任意一种;Wherein, R 1a , R 1b and R 1c are independently represented by any one of a hydrogen atom and a halogen atom, and the halogen atom is represented by any one of a chlorine atom and a fluorine atom;

A表示为吡咯基和B中的任意一种,所述B表示为苯基、吡啶基和噻唑基中的任意一种;A represents any one of pyrrolyl and B, and said B represents any one of phenyl, pyridyl and thiazolyl;

R2表示为氢原子和甲基中的任意一种;R 2 represents any one of a hydrogen atom and a methyl group;

R3表示为-CH2C(O)NHCH2CF3、-OCH3、-CH2COOCH3和6-氯嘧啶基中的任意一种。R 3 represents any one of -CH 2 C(O)NHCH 2 CF 3 , -OCH 3 , -CH 2 COOCH 3 and 6-chloropyrimidinyl.

本发明含三氟甲烷异噁唑啉类衍生物的有益效果是:The beneficial effects of the trifluoromethane-containing isoxazoline derivatives of the present invention are:

含三氟甲烷异噁唑啉类衍生物对有害昆虫具有较好的杀虫活性,尤其是对玉米螟和果蝇具有较好的防止效果,能够有效的进行生产,可作为有害昆虫杀虫剂使用。Isoxazoline derivatives containing trifluoromethane have good insecticidal activity against harmful insects, especially for corn borers and fruit flies, can be effectively produced, and can be used as insecticides for harmful insects use.

在上述技术方案的基础上,本发明还可以做如下改进。On the basis of the above technical solutions, the present invention can also be improved as follows.

进一步的,所述含三氟甲烷异噁唑啉类衍生物的化学结构式如通式I-1和通式I-2所示:Further, the chemical structural formulas of the trifluoromethane-containing isoxazoline derivatives are shown in general formula I-1 and general formula I-2:

Figure BDA0003630191230000031
Figure BDA0003630191230000031

其中,R1a、R1b和R1c彼此独立的表示为氢原子和卤素原子中的任意一种,所述卤素原子表示为氯原子和氟原子中的任意一种;Wherein, R 1a , R 1b and R 1c are independently represented by any one of a hydrogen atom and a halogen atom, and the halogen atom is represented by any one of a chlorine atom and a fluorine atom;

B表示为苯基、吡啶基和噻唑基中的任意一种;B represents any one of phenyl, pyridyl and thiazolyl;

R2表示为氢原子和甲基中的任意一种;R 2 represents any one of a hydrogen atom and a methyl group;

R3表示为-CH2C(O)NHCH2CF3、-OCH3、-CH2COOCH3和6-氯嘧啶基中的任意一种。R 3 represents any one of -CH 2 C(O)NHCH 2 CF 3 , -OCH 3 , -CH 2 COOCH 3 and 6-chloropyrimidinyl.

采用上述进一步方案的有益效果是:卤素原子采用氯原子和氟原子能够进一步提升化合物的杀虫活性。The beneficial effect of adopting the above-mentioned further scheme is that the use of chlorine atom and fluorine atom as the halogen atom can further enhance the insecticidal activity of the compound.

进一步的,所述含三氟甲烷异噁唑啉类衍生物包括如下具体结构式:Further, the trifluoromethane-containing isoxazoline derivatives include the following specific structural formula:

Figure BDA0003630191230000041
Figure BDA0003630191230000041

采用上述进一步方案的有益效果是:上述结构式的化合物对玉米螟或果蝇具有更好的杀虫活性。The beneficial effect of adopting the above-mentioned further scheme is that the compound of the above-mentioned structural formula has better insecticidal activity against corn borer or fruit fly.

本发明还提供上述含三氟甲烷异噁唑啉类衍生物的制备方法,反应式如下:The present invention also provides the preparation method of the above-mentioned trifluoromethane-containing isoxazoline derivatives, and the reaction formula is as follows:

Figure BDA0003630191230000051
Figure BDA0003630191230000051

反应式一Reaction one

Figure BDA0003630191230000052
Figure BDA0003630191230000052

反应式二Reaction two

Figure BDA0003630191230000061
Figure BDA0003630191230000061

反应式三Reaction three

Figure BDA0003630191230000071
Figure BDA0003630191230000071

反应式四Reaction four

其中,R1a、R1b和R1c彼此独立的表示为氢原子和卤素原子中的任意一种;B表示为苯基、吡啶基和噻唑基中的任意一种;Wherein, R 1a , R 1b and R 1c independently represent any one of hydrogen atom and halogen atom; B represents any one of phenyl, pyridyl and thiazolyl;

R2表示为氢原子和甲基中的任意一种;R 2 represents any one of a hydrogen atom and a methyl group;

R3表示为-CH2C(O)NHCH2CF3、-OCH3、-CH2COOCH3和6-氯嘧啶基中的任意一种;R 3 represents any one of -CH 2 C(O)NHCH 2 CF 3 , -OCH 3 , -CH 2 COOCH 3 and 6-chloropyrimidinyl;

R4、R5彼此独立的表示为甲基和乙基中的任意一种;R 4 and R 5 are independently represented by any one of methyl and ethyl;

制备包括以下步骤:Preparation includes the following steps:

步骤A:如反应式一所示,将化合物a、卤代-三氟-烯烃、催化剂和碱在溶剂中进行反应,制得中间体a;Step A: As shown in reaction formula 1, compound a, halogenated-trifluoro-alkene, catalyst and base are reacted in a solvent to obtain intermediate a;

步骤B:如反应式二所示,将化合物b与氰化亚铜在DMF中反应,得到中间体b1;将中间体b1、盐酸羟胺与醋酸钠在乙醇中反应,得到中间体c;将中间体c、亚硝酸钠和质量浓度11.5%的盐酸反应,得到中间体d1;Step B: as shown in reaction formula 2, react compound b with cuprous cyanide in DMF to obtain intermediate b1; react intermediate b1, hydroxylamine hydrochloride and sodium acetate in ethanol to obtain intermediate c; Body c, sodium nitrite and hydrochloric acid with a mass concentration of 11.5% are reacted to obtain intermediate d1;

或将化合物c、N,N-二甲基甲酰胺和三氯氧磷在二氯甲烷中反应,得到中间体b2;将中间体b2与盐酸羟胺与醋酸钠在乙醇中反应,得到中间体d2;Or react compound c, N,N-dimethylformamide and phosphorus oxychloride in dichloromethane to obtain intermediate b2; react intermediate b2 with hydroxylamine hydrochloride and sodium acetate in ethanol to obtain intermediate d2 ;

步骤C:如反应式三所示,将步骤A的中间体a、步骤B的中间体d1和TEA在DMF中反应,得到中间体e1;Step C: As shown in reaction formula 3, the intermediate a of step A, the intermediate d1 of step B and TEA are reacted in DMF to obtain intermediate e1;

或将步骤A的中间体a、步骤B的中间体d2、氯化钾和过硫酸钾在甲醇中反应,得到中间体e2;Or react the intermediate a of step A, the intermediate d2 of step B, potassium chloride and potassium persulfate in methanol to obtain intermediate e2;

步骤D:如反应式四所示,将中间体e1和氢氧化钠在乙醇中反应,得到中间体f1;将中间体f1、DPPA、TEA和R3-NH2在DMF中反应,得到通式I-1所示的化合物;Step D: as shown in reaction formula 4, the intermediate e1 and sodium hydroxide are reacted in ethanol to obtain the intermediate f1; the intermediate f1, DPPA, TEA and R 3 -NH 2 are reacted in DMF to obtain the general formula The compound shown in I-1;

或将中间体e2和氢氧化钠在乙醇中反应,得到中间体f2;将中间体f2、DPPA、TEA和R3-NH2在DMF中反应,得到通式I-2所示的化合物,通式I-1所示的化合物和通式I-2所示的化合物均为含三氟甲烷异噁唑啉类衍生物。Or react intermediate e2 and sodium hydroxide in ethanol to obtain intermediate f2; react intermediate f2, DPPA, TEA and R 3 -NH 2 in DMF to obtain a compound represented by general formula I-2, which is generally The compound represented by the formula I-1 and the compound represented by the general formula I-2 are both trifluoromethane-containing isoxazoline derivatives.

采用上述制备方法的有益效果是:采用上述制备方法,能够合成如通式I所示的含三氟甲烷异噁唑啉类衍生物,工艺路线简单,产品加工成本低。The beneficial effects of adopting the above preparation method are: by adopting the above preparation method, the trifluoromethane-containing isoxazoline derivatives as shown in general formula I can be synthesized, the process route is simple, and the product processing cost is low.

进一步的,步骤A中,所述化合物a、所述卤代-三氟-烯烃、所述催化剂和所述碱反应的摩尔比为1:(1.2~2.0):(0.015~0.03):(1.1~1.5),所述反应的温度为80~90℃,反应时间3~5h;Further, in step A, the molar ratio of the compound a, the halogenated-trifluoro-olefin, the catalyst and the base in the reaction is 1:(1.2-2.0):(0.015-0.03):(1.1 ~1.5), the temperature of the reaction is 80 ~ 90 ℃, and the reaction time is 3 ~ 5h;

所述卤代-三氟-烯烃为2-溴-3,3,3-三氟-1-丙烯;The halogenated-trifluoro-alkene is 2-bromo-3,3,3-trifluoro-1-propene;

所述溶剂为四氢呋喃、1,4-二氧六环、N,N二甲基甲酰胺、四氢呋喃和水中的任意一种或多种;The solvent is any one or more of tetrahydrofuran, 1,4-dioxane, N,N dimethylformamide, tetrahydrofuran and water;

所述催化剂为四(三苯基膦)钯和双(三苯基膦)二氯化钯中的任意一种;Described catalyst is any one in tetrakis (triphenylphosphine) palladium and bis (triphenylphosphine) palladium dichloride;

所述碱为碳酸钠、碳酸钾和碳酸铯中的任意一种。The alkali is any one of sodium carbonate, potassium carbonate and cesium carbonate.

采用上述进一步方案的有益效果是:上述配比的原料进行铃木偶联反应能够获得更高收率的中间体a。The beneficial effect of adopting the above-mentioned further scheme is: the Suzuki coupling reaction of the raw materials in the above-mentioned proportions can obtain the intermediate a with a higher yield.

进一步的,步骤B中,所述化合物b与所述氰化亚铜的摩尔比为1:(1.5~3.0),所述反应的温度为140~170℃,反应时间为2~8h;Further, in step B, the molar ratio of the compound b to the cuprous cyanide is 1:(1.5-3.0), the reaction temperature is 140-170°C, and the reaction time is 2-8h;

所述中间体b1、所述盐酸羟胺和所述醋酸钠的摩尔比为1:(1.1~1.5):(1.1~1.5),所述反应的温度为70~90℃,反应时间为1~4.5h;The molar ratio of the intermediate b1, the hydroxylamine hydrochloride and the sodium acetate is 1:(1.1-1.5):(1.1-1.5), the reaction temperature is 70-90°C, and the reaction time is 1-4.5 h;

所述中间体b2、所述盐酸羟胺和所述醋酸钠的摩尔比为1:(1.1~1.5):(1.1~1.5),所述反应的温度为70~90℃,反应时间为1~4.5h。The molar ratio of the intermediate b2, the hydroxylamine hydrochloride and the sodium acetate is 1:(1.1-1.5):(1.1-1.5), the reaction temperature is 70-90°C, and the reaction time is 1-4.5 h.

采用上述进一步方案的有益效果是:上述配比的原料进行反应,能够分别反应得到中间体d1和中间体d2,反应效率高。The beneficial effect of adopting the above-mentioned further scheme is that: the raw materials in the above proportions are reacted, and the intermediate d1 and the intermediate d2 can be respectively obtained by the reaction, and the reaction efficiency is high.

进一步的,步骤C中,所述中间体a与所述中间体d1的摩尔比为1:(1.1~1.8),所述反应的温度为50~70℃,反应时间6~12h。Further, in step C, the molar ratio of the intermediate a to the intermediate d1 is 1:(1.1-1.8), the reaction temperature is 50-70° C., and the reaction time is 6-12 h.

采用上述进一步方案的有益效果是:上述配比的原料反应生成中间体e1的效率高。The beneficial effect of adopting the above-mentioned further scheme is that: the efficiency of the reaction of the raw materials in the above-mentioned proportions to generate the intermediate e1 is high.

进一步的,步骤D中,所述中间体f1、所述DPPA、所述TEA和所述R3-NH2的摩尔比为1:(1.0~1.8):(0.2~0.5):(1.0~1.8),所述反应的温度为0℃或25~35℃,反应时间10~20h;Further, in step D, the molar ratio of the intermediate f1, the DPPA, the TEA and the R 3 -NH 2 is 1:(1.0-1.8):(0.2-0.5):(1.0-1.8 ), the temperature of the reaction is 0°C or 25-35°C, and the reaction time is 10-20h;

所述中间体f2、所述DPPA、所述TEA和所述R3-NH2的摩尔比为1:(1.0~1.8):(0.2~0.5):(1.0~1.8),所述反应的温度为0℃或25~35℃,反应时间10~20h。The molar ratio of the intermediate f2, the DPPA, the TEA and the R 3 -NH 2 is 1:(1.0-1.8):(0.2-0.5):(1.0-1.8), and the reaction temperature It is 0℃ or 25~35℃, and the reaction time is 10~20h.

采用上述进一步方案的有益效果是:采用上述原料的配比,能够使得中间体e1和中间体e2分别反应生成通式I-1和通式I-2对应的化合物,通式I-1和通式I-2对应的化合物即为通式I对应的结构。The beneficial effect of adopting the above-mentioned further scheme is: adopting the ratio of the above-mentioned raw materials, the intermediate e1 and the intermediate e2 can be respectively reacted to generate the corresponding compounds of the general formula I-1 and the general formula I-2, and the general formula I-1 and the general formula The compound corresponding to the formula I-2 is the structure corresponding to the general formula I.

本发明提供了一种含三氟甲烷异噁唑啉类衍生物,或其农药学可接受的盐在制备杀虫剂中的应用。The present invention provides the application of a trifluoromethane-containing isoxazoline derivative or a pesticide acceptable salt thereof in the preparation of pesticides.

有益效果是:采用本发明的含三氟甲烷异噁唑啉类衍生物,具有较好的杀虫活性,能够有效的杀灭玉米螟、果蝇等有害昆虫。The beneficial effects are as follows: the trifluoromethane-containing isoxazoline derivatives of the present invention have better insecticidal activity and can effectively kill harmful insects such as corn borers and fruit flies.

上述的应用,所述杀虫剂包括上述含三氟甲烷异噁唑啉类衍生物,或其农药学可接受的盐,以及至少一种农药学可接受的赋型剂;赋型剂优选字DMSO、蔗糖溶液、水和人工饲料中的任意一种或多种,如在需要杀灭玉米螟时,采用人工饲料作为本发明杀虫剂的赋型剂,进而杀灭玉米螟。Above-mentioned application, described insecticide comprises above-mentioned trifluoromethane isoxazoline derivatives, or its pesticide acceptable salt, and at least one pesticide acceptable excipient; excipient preferably word Any one or more of DMSO, sucrose solution, water and artificial feed, for example, when the corn borer needs to be killed, the artificial feed is used as the excipient of the pesticide of the present invention, and then the corn borer is killed.

具体实施方式Detailed ways

以下对本发明的原理和特征进行描述,所举实例只用于解释本发明,并非用于限定本发明的范围。The principles and features of the present invention are described below, and the examples are only used to explain the present invention, but not to limit the scope of the present invention.

实施例1Example 1

化合物1:Compound 1:

Figure BDA0003630191230000101
Figure BDA0003630191230000101

化合物1的制备路线如下:The preparation route of compound 1 is as follows:

Figure BDA0003630191230000102
Figure BDA0003630191230000102

Figure BDA0003630191230000111
Figure BDA0003630191230000111

化合物1的制备,具体为:The preparation of compound 1, specifically:

1、在100mL双口圆底烧瓶中,加入1.0mol的3,5-二氯苯硼酸、1.0mol的2-溴-3,3,3-三氟-1-丙烯、2.0mol碳酸钾、0.015mmol四(三苯基膦)钯、40mL四氢呋喃、20mL蒸馏水,氩气保护,于80℃下加热回流约8h,TLC监测反应完全后,反应液冷却至室温,加入20mL蒸馏水,乙酸乙酯萃取三次,每次30mL,将有机相用无水硫酸钠干燥,抽滤,滤液减压浓缩,得到黄色液体,经硅胶柱层析分离纯化,得到中间体1a;1. In a 100mL double-necked round bottom flask, add 1.0mol of 3,5-dichlorophenylboronic acid, 1.0mol of 2-bromo-3,3,3-trifluoro-1-propene, 2.0mol of potassium carbonate, 0.015 mmol tetrakis (triphenylphosphine) palladium, 40 mL of tetrahydrofuran, 20 mL of distilled water, under argon protection, heated to reflux at 80 ° C for about 8 h, after monitoring the completion of the reaction by TLC, the reaction solution was cooled to room temperature, 20 mL of distilled water was added, and ethyl acetate was extracted three times , 30 mL each time, the organic phase was dried with anhydrous sodium sulfate, suction filtered, and the filtrate was concentrated under reduced pressure to obtain a yellow liquid, which was separated and purified by silica gel column chromatography to obtain Intermediate 1a;

2、在250mL双口圆底烧瓶中,依次加入1.0mol的5-溴吡啶-2-硼酸、25mL的N,N-二甲基甲酰胺、2.0mol氰化亚铜,搅拌;升温至170℃反应2.5h,TLC监测反应完全后,将反应液冷却至室温,加入50mL蒸馏水和100mL乙酸乙酯搅拌1h;将反应液抽滤,滤液分层,保留有机相;水相用乙酸乙酯萃取三次,每次35mL,将有机相用饱和食盐水洗涤两次,每次20mL,无水硫酸钠干燥,抽滤,滤液减压浓缩,得到棕色液体,粗产品经硅胶柱层析分离纯化,得到中间体1b;2. In a 250mL double-necked round-bottomed flask, add 1.0mol of 5-bromopyridine-2-boronic acid, 25mL of N,N-dimethylformamide, and 2.0mol of cuprous cyanide in turn, and stir; the temperature is raised to 170°C After the reaction was completed for 2.5 h, TLC monitoring was completed, the reaction solution was cooled to room temperature, 50 mL of distilled water and 100 mL of ethyl acetate were added and stirred for 1 h; the reaction solution was suction filtered, the filtrate was separated, and the organic phase was retained; the aqueous phase was extracted three times with ethyl acetate , 35 mL each time, the organic phase was washed twice with saturated brine, 20 mL each time, dried over anhydrous sodium sulfate, suction filtered, and the filtrate was concentrated under reduced pressure to obtain a brown liquid. The crude product was separated and purified by silica gel column chromatography to obtain an intermediate body 1b;

3、在100mL单口圆底烧瓶中,依次加入1.0mol中间体1d、25mL甲醇、1.1mol盐酸羟胺和1.1mol醋酸钠,升温至80℃回流反应3h,TLC监测反应完全后,将反应液冷却至室温,减压浓缩除去甲醇,得到淡黄色固体,粗产品经硅胶柱层析分离纯化,得到中间体1c;3. In a 100mL single-necked round-bottomed flask, add 1.0mol of intermediate 1d, 25mL of methanol, 1.1mol of hydroxylamine hydrochloride and 1.1mol of sodium acetate in sequence, and heat up to 80°C for reflux reaction for 3h. After monitoring the completion of the reaction by TLC, cool the reaction solution to At room temperature, the methanol was concentrated under reduced pressure to obtain a pale yellow solid. The crude product was separated and purified by silica gel column chromatography to obtain Intermediate 1c;

4、在100mL单口圆底烧瓶中,加入1.0mol中间体1c、30mL的11.5%稀盐酸,取1.2mol亚硝酸钠,加蒸馏水溶解,冰浴下缓慢滴加至上述反应液中,并在该温度下反应3h,将反应升温至35℃继续反应3h,TLC监测反应完全后,用二氯甲烷萃取三次,每次30mL,将有机相合并,用饱和食盐水洗涤两次,每次20mL,无水硫酸镁干燥,抽滤,滤液减压浓缩,得到黄色固体。粗产品经硅胶柱层析分离纯化,得到关键中间体1d;4. In a 100mL single-neck round-bottom flask, add 1.0mol of intermediate 1c, 30mL of 11.5% dilute hydrochloric acid, take 1.2mol of sodium nitrite, dissolve in distilled water, and slowly add it dropwise to the above reaction solution under ice bath, and in this The reaction was carried out at the same temperature for 3 h, and the reaction was heated to 35 °C and continued to react for 3 h. After monitoring the completion of the reaction by TLC, it was extracted three times with dichloromethane, each 30 mL, and the organic phases were combined and washed twice with saturated brine, each 20 mL, without Dry over magnesium sulfate, filter with suction, and concentrate the filtrate under reduced pressure to obtain a yellow solid. The crude product was separated and purified by silica gel column chromatography to obtain the key intermediate 1d;

5、在100mL圆底烧瓶中,加入1.0mol中间体1a、1.2mol中间体1d和10mL的N,N-二甲基甲酰胺,再向上述反应液中滴加2.0mol三乙胺,将反应液升温至55℃搅拌反应12h,TLC监测反应完全后,向反应液中加入20mL蒸馏水搅拌,用乙酸乙酯萃取三次,每次25mL,将有机相合并,饱和食盐水洗涤两次,每次20mL,无水硫酸钠干燥,抽滤,滤液减压浓缩,得到棕色液体,经硅胶柱层析分离纯化,得到环合中间体1e;5. In a 100 mL round-bottomed flask, add 1.0 mol of intermediate 1a, 1.2 mol of intermediate 1d and 10 mL of N,N-dimethylformamide, and then add 2.0 mol of triethylamine dropwise to the above reaction solution to react The temperature of the liquid was raised to 55 °C and the reaction was stirred for 12 h. After the completion of the reaction was monitored by TLC, 20 mL of distilled water was added to the reaction solution and stirred, extracted with ethyl acetate three times, 25 mL each time, the organic phases were combined, and the saturated brine was washed twice, 20 mL each time. , dried over anhydrous sodium sulfate, suction filtered, and the filtrate was concentrated under reduced pressure to obtain a brown liquid, which was separated and purified by silica gel column chromatography to obtain cyclization intermediate 1e;

6、在50mL单口圆底烧瓶中,加入1.0mol中间体1e、15mL甲醇和5mL的4N氢氧化钠溶液,反应液升温至60℃回流反应3h,TLC监测反应完全后,减压浓缩除去甲醇溶剂,乙酸乙酯萃取三次,每次25mL,将有机相合并,饱和食盐水洗涤两次,每次20mL,无水硫酸钠干燥,抽滤,滤液减压浓缩,得到中间体1f;6. In a 50mL single-neck round-bottom flask, add 1.0mol of intermediate 1e, 15mL of methanol and 5mL of 4N sodium hydroxide solution, the reaction solution is heated to 60°C and refluxed for 3h, after monitoring the completion of the reaction by TLC, concentrate under reduced pressure to remove the methanol solvent , extracted with ethyl acetate three times, 25 mL each time, the organic phases were combined, washed with saturated brine twice, 20 mL each time, dried over anhydrous sodium sulfate, suction filtered, and the filtrate was concentrated under reduced pressure to obtain Intermediate 1f;

7、在50mL单口圆底烧瓶中,加入1.0mol中间体1f、5mL的DMF和叠1.0mol氮磷酸二苯酯,冰浴下滴加0.2mol三乙胺,并在该温度下反应1h,将反应液升至室温,加入化合物1.0mol的CF3CH2NH(O)CCH2-NH2的盐酸盐,搅拌反应12h,TLC监测反应完全后,加入20mL蒸馏水和40mL乙酸乙酯搅拌30min,溶液分层,水相乙酸乙酯萃取三次,每次25mL,将有机相合并,用蒸馏水洗涤两次,每次20mL,再用饱和食盐水洗涤两次,每次20mL,无水硫酸钠干燥,抽滤,滤液减压浓缩,得到淡黄色固体,经硅胶柱层析分离纯化,得到化合物1。7. In a 50mL single-neck round-bottom flask, add 1.0mol of intermediate 1f, 5mL of DMF and 1.0mol of diphenyl nitrophosphate, dropwise add 0.2mol of triethylamine under an ice bath, and react at this temperature for 1h, the The reaction solution was warmed to room temperature, 1.0 mol of the compound CF 3 CH 2 NH(O)CCH 2 -NH 2 hydrochloride was added, and the reaction was stirred for 12 h. After monitoring the completion of the reaction by TLC, 20 mL of distilled water and 40 mL of ethyl acetate were added and stirred for 30 min. The solution layers were separated, the aqueous phase was extracted three times with 25 mL of ethyl acetate, the organic phases were combined, washed with distilled water twice, with 20 mL each, and washed with saturated brine twice, with 20 mL each, and dried over anhydrous sodium sulfate. Suction filtration, and the filtrate was concentrated under reduced pressure to obtain a pale yellow solid, which was separated and purified by silica gel column chromatography to obtain compound 1.

化合物1的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 1 are as follows:

5-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-N-[(2,2,2-三氟乙基氨基)-乙基]-吡啶甲酰胺,白色固体,产率85.3%;5-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-[(2,2,2-trifluoro Ethylamino)-ethyl]-pyridinecarboxamide, white solid, 85.3% yield;

1H NMR(400MHz,DMSO-d6)δ9.05(t,J=6.1Hz,1H),8.94(d,J=2.1Hz,1H),8.64(t,J=6.4Hz,1H),8.31(d,J=8.2Hz,1H),8.12(d,J=8.2Hz,1H),7.80(s,1H),7.62(s,2H),4.51(d,J=18.4Hz,1H),4.38(d,J=18.5Hz,1H),3.98(d,J=6.0Hz,2H),3.90(tt,J=9.9,4.8Hz,2H);13C NMR(101MHz,DMSO-d6)δ169.94,163.93,156.33,151.50,147.41,139.01,136.54,135.17,130.78,130.12,126.54,126.46,126.14,123.76,122.51,87.68,87.38,43.00,42.63,29.47;HRMS m/z calcd for C20H14Cl2F6N4O3[M+H]+543.0425,found543.0424. 1 H NMR (400MHz, DMSO-d 6 ) δ 9.05 (t, J=6.1 Hz, 1H), 8.94 (d, J=2.1 Hz, 1H), 8.64 (t, J=6.4 Hz, 1H), 8.31 (d, J=8.2Hz, 1H), 8.12 (d, J=8.2Hz, 1H), 7.80 (s, 1H), 7.62 (s, 2H), 4.51 (d, J=18.4Hz, 1H), 4.38 (d, J=18.5Hz, 1H), 3.98 (d, J=6.0Hz, 2H), 3.90 (tt, J=9.9, 4.8Hz, 2H); 13 C NMR (101MHz, DMSO-d 6 )δ169. 94,163.93,156.33,151.50,147.41,139.01,136.54,135.17,130.78,130.12,126.54,126.46,126.14,123.76,122.51,87.68,87.38,43.00,42.63,29.47;HRMS m/z calcd for C 20 H 14 Cl 2 F 6 N 4 O 3 [M+H] + 543.0425, found543.0424.

实施例2Example 2

化合物2:Compound 2:

Figure BDA0003630191230000141
Figure BDA0003630191230000141

化合物2的制备流程与实施例1相同,本实施例与实施例不同之处在于:步骤7中的CF3CH2NH(O)CCH2-NH2替换为CH3-O-NH2The preparation process of compound 2 is the same as that of Example 1, and the difference between this example and Example is that CF 3 CH 2 NH(O)CCH 2 -NH 2 in step 7 is replaced by CH 3 -O-NH 2 .

化合物2的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 2 are as follows:

5-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-N-甲氧基-吡啶甲酰胺,白色固体,产率90.2%;5-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-methoxy-picolinamide, white solid , the yield is 90.2%;

1H NMR(400MHz,DMSO-d6)δ12.22(s,1H),8.90(s,1H),8.31(dd,J=8.2,2.2Hz,1H),8.11(d,J=8.1Hz,1H),7.83(s,1H),7.64(s,2H),4.52(d,J=18.4Hz,1H),4.40(d,J=18.5Hz,1H),3.72(s,3H);13C NMR(101MHz,DMSO-d6)δ160.85,156.32,151.51,147.35,139.01,136.50,135.17,130.13,126.53,126.14,122.67,87.69,87.39,63.70,42.98;HRMSm/z calcd for C17H12Cl2F3N3O3[M+H]+434.0286,found 434.0283. 1 H NMR (400MHz, DMSO-d 6 ) δ 12.22 (s, 1H), 8.90 (s, 1H), 8.31 (dd, J=8.2, 2.2 Hz, 1H), 8.11 (d, J=8.1 Hz, 1H), 7.83(s, 1H), 7.64(s, 2H), 4.52(d, J=18.4Hz, 1H), 4.40(d, J=18.5Hz, 1H), 3.72(s, 3H); 13 C HRMS m / z F 3 N 3 O 3 [M+H] + 434.0286, found 434.0283.

实施例3Example 3

化合物3:Compound 3:

Figure BDA0003630191230000151
Figure BDA0003630191230000151

化合物3的制备与实施例1相同,本实施例与实施例1不同之处在于:步骤7中的CF3CH2NH(O)CCH2-NH2替换为CH3NHO(O)CCH2-NH2The preparation of compound 3 is the same as that of Example 1. The difference between this example and Example 1 is that: CF 3 CH 2 NH(O)CCH 2 -NH 2 in step 7 is replaced by CH 3 NHO(O)CCH 2 - NH2 .

化合物3的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 3 are as follows:

5-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-吡啶甘胺酸甲酯,白色固体,产率91.4%;5-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-pyridineglycine methyl ester, white solid, yield 91.4%;

1H NMR(400MHz,DMSO-d6)δ9.24(t,J=6.1Hz,1H),8.94(s,1H),8.31(d,J=10.4Hz,1H),8.12(d,J=8.2Hz,1H),7.80(s,1H),7.62(s,2H),4.51(d,J=18.4Hz,1H),4.39(d,J=18.5Hz,1H),4.06(d,J=6.1Hz,2H),3.64(s,3H);13C NMR(101MHz,DMSO-d6)δ170.52,164.08,156.33,151.29,147.52,139.02,136.60,135.17,130.12,126.60,126.15,125.63,122.57,87.70,87.40,52.29,43.01,41.51;HRMS m/z calcd for C19H14Cl2F3N3O4[M+H]+476.0392,found 476.0390. 1 H NMR (400MHz, DMSO-d 6 ) δ 9.24(t, J=6.1Hz, 1H), 8.94(s, 1H), 8.31(d, J=10.4Hz, 1H), 8.12(d, J= 8.2Hz, 1H), 7.80(s, 1H), 7.62(s, 2H), 4.51(d, J=18.4Hz, 1H), 4.39(d, J=18.5Hz, 1H), 4.06(d, J= 6.1Hz, 2H), 3.64(s, 3H); 13 C NMR (101MHz, DMSO-d 6 ) δ 170.52, 164.08, 156.33, 151.29, 147.52, 139.02, 136.60, 135.17, 130.12, 126.60, 126.15, 125.63, 1225.63 87.70, 87.40, 52.29, 43.01, 41.51; HRMS m/z calcd for C 19 H 14 Cl 2 F 3 N 3 O 4 [M+H] + 476.0392, found 476.0390.

实施例4Example 4

化合物4:Compound 4:

Figure BDA0003630191230000152
Figure BDA0003630191230000152

化合物4的制备与实施例1相同,本实施例与实施例1不同之处在于:步骤2中的5-溴吡啶-2-硼酸替换为5-溴(3-甲基)吡啶-2-硼酸。The preparation of compound 4 is the same as that of Example 1. The difference between this example and Example 1 is that the 5-bromopyridine-2-boronic acid in step 2 is replaced with 5-bromo(3-methyl)pyridine-2-boronic acid. .

化合物4的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 4 are as follows:

5-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-3-甲基-N-[(2,2,2-三氟乙基氨基)-乙基]-吡啶甲酰胺,白色固体,产率86.7%;5-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-3-methyl-N-[(2,2 ,2-Trifluoroethylamino)-ethyl]-picolinamide, white solid, yield 86.7%;

1H NMR(400MHz,DMSO-d6)δ8.92(t,J=6.0Hz,1H),8.78(s,1H),8.62(t,J=6.3Hz,1H),8.10(s,1H),7.82(s,1H),7.63(s,2H),4.49(s,1H),4.37(s,1H),3.98–3.89(m,4H),2.61(s,3H);13C NMR(101MHz,DMSO-d6)δ170.06,165.92,156.21,150.24,144.48,139.04,135.17,134.53,130.11,126.56,126.15,125.53,123.79,87.53,87.23,43.07,42.48,29.46,19.80;HRMS m/z calcd for C21H16Cl2F6N4O3[M+H]+557.0582,found 557.0581. 1 H NMR (400MHz, DMSO-d 6 ) δ 8.92(t, J=6.0Hz, 1H), 8.78(s, 1H), 8.62(t, J=6.3Hz, 1H), 8.10(s, 1H) , 7.82(s, 1H), 7.63(s, 2H), 4.49(s, 1H), 4.37(s, 1H), 3.98–3.89(m, 4H), 2.61(s, 3H); 13 C NMR (101MHz) ,DMSO-d 6 )δ170.06,165.92,156.21,150.24,144.48,139.04,135.17,134.53,130.11,126.56,126.15,125.53,123.79,87.53,87.23,43.07,42.48; C 21 H 16 Cl 2 F 6 N 4 O 3 [M+H] + 557.0582, found 557.0581.

实施例5Example 5

化合物5:Compound 5:

Figure BDA0003630191230000161
Figure BDA0003630191230000161

化合物5的制备与实施例1相同,本实施例与实施例1不同之处在于:步骤2中的5-溴吡啶-2-硼酸替换为5-溴(3-甲基)吡啶-2-硼酸;步骤7中的CF3CH2NH(O)CCH2-NH2为CF3CH2NH(O)CCH2-NH2为CH3-O-NH2The preparation of compound 5 is the same as that of Example 1. The difference between this example and Example 1 is that the 5-bromopyridine-2-boronic acid in step 2 is replaced with 5-bromo(3-methyl)pyridine-2-boronic acid. ; CF3CH2NH(O)CCH2- NH2 in step 7 is CF3CH2NH(O ) CCH2 - NH2 is CH3 - O - NH2 .

化合物5的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 5 are as follows:

5-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-N-甲氧基-3-甲基-吡啶甲酰胺,白色固体,产率91.2%;5-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-methoxy-3-methyl-pyridine Formamide, white solid, 91.2% yield;

1H NMR(400MHz,CDCl3)δ10.22(s,1H),8.63(d,J=2.1Hz,1H),7.86(d,J=2.1Hz,1H),7.50(d,J=1.9Hz,2H),7.43(t,J=1.9Hz,1H),4.09(d,J=17.3Hz,1H),3.89(s,3H),3.72(d,J=17.3Hz,1H),2.75(s,3H);13C NMR(101MHz,DMSO-d6)δ170.64,166.15,156.22,150.15,144.59,139.07,139.03,135.17,134.43,130.13,126.15,125.60,87.54,87.24,52.24,43.08,41.34,19.67;HRMS m/z calcd for C18H14Cl2F3N3O3[M+H]+448.0443,found448.0437. 1 H NMR (400 MHz, CDCl 3 ) δ 10.22 (s, 1H), 8.63 (d, J=2.1 Hz, 1H), 7.86 (d, J=2.1 Hz, 1H), 7.50 (d, J=1.9 Hz ,2H),7.43(t,J=1.9Hz,1H),4.09(d,J=17.3Hz,1H),3.89(s,3H),3.72(d,J=17.3Hz,1H),2.75(s , 3H); 13 C NMR (101MHz, DMSO-d 6 ) δ 170.64, 166.15, 156.22, 150.15, 144.59, 139.07, 139.03, 135.17, 134.43, 130.13, 126.15, 125.60, 87.54, 81.2, 4, 1.32. ; HRMS m/z calcd for C 18 H 14 Cl 2 F 3 N 3 O 3 [M+H] + 448.0443, found448.0437.

实施例6Example 6

化合物6:Compound 6:

Figure BDA0003630191230000171
Figure BDA0003630191230000171

化合物6的制备与实施例1相同,本实施例与实施例1不同之处在于:步骤2中的5-溴吡啶-2-硼酸替换为5-溴(3-甲基)吡啶-2-硼酸;步骤7中的CF3CH2NH(O)CCH2-NH2为CH3NHO(O)CCH2-NH2The preparation of compound 6 is the same as that of Example 1. The difference between this example and Example 1 is that the 5-bromopyridine-2-boronic acid in step 2 is replaced by 5-bromo(3-methyl)pyridine-2-boronic acid. ; CF 3 CH 2 NH(O)CCH 2 -NH 2 in step 7 is CH 3 NHO(O)CCH 2 -NH 2 .

化合物6的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 6 are as follows:

5-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-3-甲基-吡啶甘氨酸甲酯,白色固体,产率90.9%;5-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-3-methyl-pyridineglycine methyl ester, white solid , the yield is 90.9%;

1H NMR(400MHz,DMSO-d6)δ9.08(t,J=6.1Hz,1H),8.76(d,J=2.0Hz,1H),8.08(d,J=2.0Hz,1H),7.81(t,J=1.9Hz,1H),7.61(d,J=1.9Hz,2H),4.48(d,J=18.4Hz,1H),4.35(d,J=18.5Hz,1H),4.01(d,J=6.1Hz,2H),3.64(s,3H),2.57(s,3H);13C NMR(101MHz,DMSO-d6)δ170.64,166.14,156.21,150.13,144.58,139.07,139.03,135.17,134.44,130.12,126.15,125.60,87.54,87.24,52.24,43.07,41.33,19.68;HRMS m/z calcd forC20H16Cl2F3N3O4[M+H]+490.0548,found 490.0551. 1 H NMR (400MHz, DMSO-d 6 )δ9.08(t,J=6.1Hz,1H),8.76(d,J=2.0Hz,1H),8.08(d,J=2.0Hz,1H),7.81 (t, J=1.9Hz, 1H), 7.61(d, J=1.9Hz, 2H), 4.48(d, J=18.4Hz, 1H), 4.35(d, J=18.5Hz, 1H), 4.01(d , J=6.1Hz, 2H), 3.64(s, 3H), 2.57(s, 3H); 13 C NMR (101MHz, DMSO-d 6 )δ170.64, 166.14, 156.21, 150.13, 144.58, 139.07, 139.03, 135.17, 134.44,130.12,126.15,125.60,87.54,87.24,52.24,43.07,41.33,19.68; HRMS m/z calcd for C 20 H 16 Cl 2 F 3 N 3 O 4 [M+H] + 490.0548, found 490.0551.

实施例7Example 7

化合物7:Compound 7:

Figure BDA0003630191230000181
Figure BDA0003630191230000181

化合物7的制备与实施例1相同,本实施例与实施例1不同之处在于:步骤2中,所采用的5-溴吡啶-2-硼酸替换为2-溴噻唑-4-硼酸。The preparation of compound 7 is the same as that of Example 1. The difference between this example and Example 1 is that in step 2, the 5-bromopyridine-2-boronic acid used is replaced with 2-bromothiazole-4-boronic acid.

化合物6的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 6 are as follows:

2-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-N-[(2,2,2-三氟乙基氨基)-乙基]-噻唑-4-甲酰胺,白色固体,产率93.2%;2-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-[(2,2,2-trifluoro Ethylamino)-ethyl]-thiazole-4-carboxamide, white solid, 93.2% yield;

1H NMR(400MHz,DMSO-d6)δ8.66(t,J=6.4Hz,1H),8.56(t,J=6.1Hz,1H),8.52(s,1H),7.81(t,J=1.9Hz,1H),7.66(d,J=1.8Hz,2H),4.43(d,J=18.5Hz,1H),4.31(d,J=18.5Hz,1H),3.97(d,J=6.2Hz,2H),3.90(td,J=9.8,6.3Hz,2H);13C NMR(101MHz,DMSO-d6)δ169.89,160.52,155.07,150.94,138.40,135.22,130.24,128.14,126.55,126.15,123.78,88.19,87.89,60.22,43.51,42.38,14.54;HRMS m/z calcd for C18H12Cl2F6N4O3[M+H]+548.9990,found 548.9987. 1 H NMR (400MHz, DMSO-d 6 ) δ 8.66(t, J=6.4Hz, 1H), 8.56(t, J=6.1Hz, 1H), 8.52(s, 1H), 7.81(t, J= 1.9Hz, 1H), 7.66 (d, J=1.8Hz, 2H), 4.43 (d, J=18.5Hz, 1H), 4.31 (d, J=18.5Hz, 1H), 3.97 (d, J=6.2Hz) , 2H), 3.90 (td, J=9.8, 6.3 Hz, 2H); 13 C NMR (101 MHz, DMSO-d 6 ) δ 169.89, 160.52, 155.07, 150.94, 138.40, 135.22, 130.24, 128.14, 126.55, 126.15, 123.78 , 88.19, 87.89, 60.22, 43.51, 42.38, 14.54; HRMS m/z calcd for C 18 H 12 Cl 2 F 6 N 4 O 3 [M+H] + 548.9990, found 548.9987.

实施例8Example 8

化合物8:Compound 8:

Figure BDA0003630191230000191
Figure BDA0003630191230000191

化合物8的制备路线如下:The preparation route of compound 8 is as follows:

Figure BDA0003630191230000192
Figure BDA0003630191230000192

化合物8的制备,具体为:The preparation of compound 8, specifically:

1、在100ml单口圆底烧瓶中,加入1.0mol的N,N-二甲基甲酰胺,冰浴下滴加1.0mol三氯氧磷,并在该温度下反应30min,取1.0mol的1H-吡咯-2-羧酸甲酯于50ml的CH2Cl2中溶解,冰浴下滴加到上述反应液中,滴加完毕后,升温至60℃回流2h,TLC监测反应完全后,将反应液冷却至室温,取5.0mol醋酸钠,于60mL蒸馏水中溶解,将反应液倒入250mL烧杯中,冰浴下加入醋酸钠溶液,反应液分层,水相二氯甲烷萃取三次,每次30mL,将有机相用饱和食盐水洗涤两次,每次20mL,无水硫酸镁干燥,抽滤,滤液减压浓缩,得到黄色固体,经硅胶柱层析分离纯化,得到中间体8b;1. In a 100ml single-neck round-bottomed flask, add 1.0mol of N,N-dimethylformamide, dropwise add 1.0mol of phosphorus oxychloride under an ice bath, and react at this temperature for 30min, take 1.0mol of 1H- Methyl pyrrole-2-carboxylate was dissolved in 50 ml of CH 2 Cl 2 , and added dropwise to the above reaction solution under ice bath. After the dropwise addition, the temperature was raised to 60°C and refluxed for 2 h. After monitoring the completion of the reaction by TLC, the reaction solution was added Cool to room temperature, take 5.0 mol of sodium acetate, dissolve it in 60 mL of distilled water, pour the reaction solution into a 250 mL beaker, add sodium acetate solution under an ice bath, layer the reaction solution, and extract the aqueous phase with dichloromethane three times, 30 mL each time, The organic phase was washed twice with 20 mL of saturated brine, dried over anhydrous magnesium sulfate, filtered with suction, and the filtrate was concentrated under reduced pressure to obtain a yellow solid, which was separated and purified by silica gel column chromatography to obtain Intermediate 8b;

2、在100mL单口圆底烧瓶中,加入1.0mol中间体8b、2.0mol盐酸羟胺、2.0mol醋酸钠和25mL甲醇,升温至80℃回流反应2h,将反应液冷却至室温,减压浓缩除去甲醇,得到淡黄色固体,硅胶柱层析分离纯化,得到中间体8d;2. In a 100mL single-neck round-bottom flask, add 1.0mol of intermediate 8b, 2.0mol of hydroxylamine hydrochloride, 2.0mol of sodium acetate and 25mL of methanol, heat up to 80°C for reflux reaction for 2h, cool the reaction solution to room temperature, and concentrate under reduced pressure to remove methanol , a pale yellow solid was obtained, which was separated and purified by silica gel column chromatography to obtain intermediate 8d;

3、在100mL单口圆底烧瓶中,加入0.02mol氯化钾和0.2mol过硫酸氢钾,加入20mL蒸馏水溶解,取实施例1的1.0mol中间体a和1.1mol中间体8d,加入40mL甲醇溶解,滴入上述反应液,室温下搅拌反应8h,TLC监测反应完全后,减压浓缩除去甲醇溶剂,剩余水相乙酸乙酯萃取三次,每次25mL,将有机相合并,饱和食盐水洗涤两次,每次20mL,无水硫酸钠干燥,抽滤,滤液减压浓缩,得到黄色液体,硅胶柱层析分离纯化,得到中间体8e;3. In a 100mL single-neck round bottom flask, add 0.02mol potassium chloride and 0.2mol potassium hydrogen persulfate, add 20mL distilled water to dissolve, take 1.0mol intermediate a and 1.1mol intermediate 8d of Example 1, add 40mL methanol to dissolve , dropwise into the above reaction solution, stir the reaction at room temperature for 8 h, after monitoring the completion of the reaction by TLC, concentrate under reduced pressure to remove the methanol solvent, extract the remaining aqueous phase with ethyl acetate three times, each 25 mL, combine the organic phases, and wash twice with saturated brine , 20 mL each time, dried over anhydrous sodium sulfate, suction filtered, and the filtrate was concentrated under reduced pressure to obtain a yellow liquid, which was separated and purified by silica gel column chromatography to obtain intermediate 8e;

4、在50mL单口圆底烧瓶中,加入1.0mol中间体8e、15mL甲醇和5mL的4N氢氧化钠溶液,反应液升温至60℃后回流反应3h,TLC监测反应完全后,减压浓缩除去甲醇溶剂,乙酸乙酯萃取三次,每次25mL,将有机相合并,饱和食盐水洗涤两次,每次20mL,无水硫酸钠干燥,抽滤,滤液减压浓缩,得到中间体8f;4. In a 50mL single-neck round-bottom flask, add 1.0mol of intermediate 8e, 15mL of methanol and 5mL of 4N sodium hydroxide solution, the reaction solution is heated to 60°C and refluxed for 3h. After monitoring the completion of the reaction by TLC, concentrate under reduced pressure to remove methanol The solvent was extracted three times with 25 mL of ethyl acetate, the organic phases were combined, washed twice with 20 mL of saturated brine, dried over anhydrous sodium sulfate, filtered with suction, and the filtrate was concentrated under reduced pressure to obtain Intermediate 8f;

5、在50mL单口圆底烧瓶中,加入1.0mol中间体8f、5mL的DMF和1.0mol,冰浴下滴加0.2mol三乙胺,并在该温度下反应1h,将反应液升至室温,加入化合物1.0mol的R3-NH2盐酸盐,搅拌反应12h,TLC监测反应完全后,加入20mL蒸馏水和40mL乙酸乙酯搅拌30min,溶液分层,水相乙酸乙酯萃取三次,每次25mL,将有机相合并,依次蒸馏水洗涤两次,每次20mL,饱和食盐水洗涤两次,每次20mL,无水硫酸钠干燥,抽滤,滤液减压浓缩,得到淡黄色固体,硅胶柱层析分离纯化,得到化合物8。5. In a 50mL single-neck round-bottom flask, add 1.0mol of intermediate 8f, 5mL of DMF and 1.0mol, dropwise add 0.2mol of triethylamine under an ice bath, and react at this temperature for 1h, and the reaction solution is raised to room temperature, 1.0 mol of compound R 3 -NH 2 hydrochloride was added, and the reaction was stirred for 12 h. After monitoring the completion of the reaction by TLC, 20 mL of distilled water and 40 mL of ethyl acetate were added and stirred for 30 min. The solution was separated, and the aqueous phase was extracted three times with 25 mL of ethyl acetate , the organic phases were combined, washed with distilled water twice, 20 mL each time, saturated brine twice, 20 mL each time, dried over anhydrous sodium sulfate, suction filtered, and the filtrate was concentrated under reduced pressure to obtain a pale yellow solid, which was subjected to silica gel column chromatography After separation and purification, compound 8 was obtained.

化合物8的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 8 are as follows:

5-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-N-[(2,2,2-三氟乙基氨基)-乙基]-1H-吡咯-2-甲酰胺,淡黄色固体,产率87.3%;5-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-N-[(2,2,2-trifluoro Ethylamino)-ethyl]-1H-pyrrole-2-carboxamide, pale yellow solid, yield 87.3%;

1H NMR(400MHz,DMSO-d6)δ12.08(s,1H),8.69–8.51(m,2H),7.80(s,1H),7.59(s,2H),6.88(s,1H),6.63(s,1H),4.34(d,J=18.2Hz,1H),4.23(d,J=18.2Hz,1H),3.92(dd,J=8.7,6.1Hz,4H);13C NMR(101MHz,DMSO-d6)δ170.39,160.44,151.50,139.27,135.12,130.52,130.00,126.55,126.12,125.75,123.77,122.92,122.28,113.39,112.96,86.59,.30,43.84,42.30;HRMS m/z calcd for C19H14Cl2F6N4O3[M+H]+531.0425,found 531.0423. 1 H NMR (400MHz, DMSO-d 6 )δ12.08(s,1H),8.69-8.51(m,2H),7.80(s,1H),7.59(s,2H),6.88(s,1H), 6.63 (s, 1H), 4.34 (d, J=18.2Hz, 1H), 4.23 (d, J=18.2Hz, 1H), 3.92 (dd, J=8.7, 6.1Hz, 4H); 13 C NMR (101MHz) ,DMSO-d 6 )δ170.39,160.44,151.50,139.27,135.12,130.52,130.00,126.55,126.12,125.75,123.77,122.92,122.28,113.39,112.96,86.59,.30; for C 19 H 14 Cl 2 F 6 N 4 O 3 [M+H] + 531.0425, found 531.0423.

实施例9Example 9

化合物9:Compound 9:

Figure BDA0003630191230000211
Figure BDA0003630191230000211

化合物9的制备与实施例1相同,本实施例与实施例1不同之处在于:The preparation of compound 9 is the same as that of Example 1, and the difference between this example and Example 1 is:

步骤1中的3,5-二氯苯硼酸替换为3,4,5-三氟苯硼酸;步骤2中的5-溴吡啶-2-硼酸替换为2-甲基-5-溴吡啶-2-硼酸。3,5-dichlorobenzeneboronic acid in step 1 was replaced with 3,4,5-trifluorobenzeneboronic acid; 5-bromopyridine-2-boronic acid in step 2 was replaced with 2-methyl-5-bromopyridine-2 - Boric acid.

化合物9的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 9 are as follows:

3-甲基-5-[5-三氟甲基-5-(3,4,5-三氟苯基)-4,5-二氢异噁唑-3-基]-吡啶甲酰胺,白色固体,产率89.2%;3-Methyl-5-[5-trifluoromethyl-5-(3,4,5-trifluorophenyl)-4,5-dihydroisoxazol-3-yl]-picolinamide, white solid, yield 89.2%;

1H NMR(400MHz,DMSO-d6)δ8.92(t,J=6.0Hz,1H),8.75(s,1H),8.63(t,J=6.4Hz,1H),8.07(s,1H),7.71–7.47(m,2H),4.47(d,J=18.4Hz,1H),4.32(d,J=18.4Hz,1H),3.92(dd,J=15.9,6.2Hz,4H),2.58(s,3H);13C NMR(101MHz,DMSO-d6)δ170.05,165.91,156.13,150.26,144.46,139.02,134.53,125.50,112.91,112.69,43.13,42.46,19.79;HRMS m/zcalcd for C21H15F9N4O3[M+H]+543.1079,found 543.1077. 1 H NMR (400MHz, DMSO-d 6 ) δ 8.92(t, J=6.0Hz, 1H), 8.75(s, 1H), 8.63(t, J=6.4Hz, 1H), 8.07(s, 1H) ,7.71–7.47(m,2H),4.47(d,J=18.4Hz,1H),4.32(d,J=18.4Hz,1H),3.92(dd,J=15.9,6.2Hz,4H),2.58( s, 3H); 13 C NMR (101 MHz, DMSO-d 6 ) δ 170.05, 165.91, 156.13, 150.26, 144.46, 139.02, 134.53, 125.50, 112.91, 112.69, 43.13, 42.46, 19.79; HRMS m/z Hd for C 21 15 F 9 N 4 O 3 [M+H] + 543.1079, found 543.1077.

实施例10Example 10

化合物10:Compound 10:

Figure BDA0003630191230000221
Figure BDA0003630191230000221

化合物10的制备与实施例1相同,本实施例与实施例1不同之处在于:The preparation of compound 10 is the same as that of Example 1, and the difference between this example and Example 1 is:

步骤2中的5-溴吡啶-2-硼酸替换为2-甲基-5-溴苯硼酸:步骤7中的CF3CH2NH(O)CCH2-NH2替换为4-氨基-6-嘧啶胺。5-Bromopyridine-2-boronic acid in step 2 was replaced with 2-methyl-5-bromophenylboronic acid: CF3CH2NH(O) CCH2 - NH2 in step 7 was replaced with 4-amino-6- Pyrimidineamine.

化合物10的物性和质谱结果如下:The physical properties and mass spectrometry results of compound 10 are as follows:

N-(6-氯嘧啶-4-基)-4-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氢异噁唑-3-基]-2-甲基苯甲酰胺,淡黄色固体,产率78.6%;N-(6-Chloropyrimidin-4-yl)-4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl] -2-methylbenzamide, pale yellow solid, yield 78.6%;

1H NMR(400MHz,DMSO-d6)δ7.76(t,J=1.9Hz,1H),7.59(d,J=1.9Hz,2H),7.29–7.23(m,2H),6.60(d,J=8.3Hz,1H),5.51(s,2H),4.18(d,J=18.1Hz,1H),4.09(d,J=18.1Hz,1H),2.04(s,3H);13C NMR(101MHz,DMSO-d6)δ157.80,150.25,139.84,135.01,129.83,129.69,126.64,126.23,125.95,123.13,121.14,114.44,113.84,86.17,85.88,43.93,17.77;HRMS m/z calcd for C22H14Cl3F3N4O2[M+H]+529.0213,found 529.0226. 1 H NMR (400MHz, DMSO-d 6 ) δ 7.76(t, J=1.9Hz, 1H), 7.59(d, J=1.9Hz, 2H), 7.29-7.23(m, 2H), 6.60(d, J=8.3Hz, 1H), 5.51(s, 2H), 4.18(d, J=18.1Hz, 1H), 4.09(d, J=18.1Hz, 1H), 2.04(s, 3H); 13 C NMR( 101MHz, DMSO-d 6 ) δ157.80,150.25,139.84,135.01,129.83,129.69,126.64,126.23,125.95,123.13,121.14,114.44,113.84,86.17,85.88,43.93,17 14Cl 3 F 3 N 4 O 2 [M+H] + 529.0213, found 529.0226.

实施例1-10所得的化合物对玉米螟的杀虫活性测试Insecticidal activity test of the compounds obtained in Example 1-10 against corn borer

采用人工饲料混药法,测定了10个化合物在100mg/kg和300mg/kg浓度下对玉米螟三龄初幼虫的杀虫活性。The insecticidal activities of 10 compounds against the third instar larvae of the corn borer were determined at the concentration of 100 mg/kg and 300 mg/kg by artificial feed mixing method.

1、试剂与材料:1. Reagents and materials:

①原药:化合物1-10①Technical drug: Compounds 1-10

②溶剂:DMSO(分析纯)②Solvent: DMSO (analytical grade)

③生物材料:玉米螟,人工饲料③Biomaterials: corn borer, artificial feed

2、实验方法:2. Experimental method:

1)配制100mg/kg的有毒饲料1) Prepare 100mg/kg toxic feed

将供试化合物原药溶解在DMSO中,配制成浓度为10000mg/kg的母液,将母液与人工饲料按质量比1:99混合,充分混匀,制成含有100mg/kg待测药剂的人工饲料。Dissolve the original drug of the test compound in DMSO, prepare a mother liquor with a concentration of 10,000 mg/kg, mix the mother liquor and artificial feed at a mass ratio of 1:99, and mix thoroughly to prepare an artificial feed containing 100 mg/kg of the drug to be tested. .

2)配制300mg/kg的有毒饲料2) Prepare 300mg/kg toxic feed

将供试化合物原药溶解在DMSO中,配制成浓度为10000mg/kg的母液,将母液与人工饲料按质量比3:97混合,充分混匀,制成含有300mg/kg待测药剂的人工饲料。Dissolve the original drug of the test compound in DMSO, prepare a mother liquor with a concentration of 10000mg/kg, mix the mother liquor and artificial feed in a mass ratio of 3:97, and mix thoroughly to prepare an artificial feed containing 300mg/kg of the drug to be tested. .

3)供试昆虫的筛选3) Screening of test insects

选取生长一致且健康的三龄初幼虫作为待试昆虫。The third instar larvae with consistent growth and healthy growth were selected as the test insects.

4)混药与接虫4) Mixing and receiving insects

在培养板的每孔加入约1.0g混毒人工饲料,并放置20头待试昆虫;处理后将培养板转移至(26±1℃)、相对湿度为40-70%和光周期L/D=6h/8h(光照、遮光分别处理16h和8h)的条件下饲养。Add about 1.0g mixed-toxic artificial feed to each well of the culture plate, and place 20 insects to be tested; after treatment, transfer the culture plate to (26±1°C), relative humidity of 40-70% and photoperiod L/D= The animals were reared under the conditions of 6h/8h (16h and 8h of light and shading, respectively).

5)检查与数据处理5) Inspection and data processing

经过48h和72h后分别统计玉米螟的死亡数量。每个待测药物重复3次实验,统计死亡数,计算死亡率和校正死亡率。After 48h and 72h, the death numbers of corn borer were counted. The experiment was repeated 3 times for each drug to be tested, and the number of deaths was counted, and the death rate and corrected death rate were calculated.

校正死亡率:P1=(Pt-P0)/(1-P0)*100%Corrected mortality: P 1 =(P t -P 0 )/(1-P 0 )*100%

式中,Pt代表实验组死亡率,P0代表对照组死亡率,P1代表校正死亡率。In the formula, P t represents the mortality rate of the experimental group, P 0 represents the mortality rate of the control group, and P 1 represents the corrected mortality rate.

3、实验结果3. Experimental results

化合物1-10在100mg/kg下对玉米螟的杀虫活性见表1;化合物1-10在300mg/kg下对玉米螟的杀虫活性见表2。The insecticidal activities of compounds 1-10 against corn borer at 100 mg/kg are shown in Table 1; the insecticidal activities of compounds 1-10 against corn borer at 300 mg/kg are shown in Table 2.

表1:Table 1:

Figure BDA0003630191230000241
Figure BDA0003630191230000241

表2:Table 2:

Figure BDA0003630191230000251
Figure BDA0003630191230000251

4、测试结果表明:4. The test results show that:

1)在化合物100mg/kg浓度下,化合物1-10均对玉米螟具有杀虫活性,其中化合物4的杀虫活性最高,化合物1、化合物8、化合物9在72h的杀虫活性均大于40%;1) At the concentration of compound 100mg/kg, compounds 1-10 all have insecticidal activity against corn borer, among which compound 4 has the highest insecticidal activity, and compound 1, compound 8, and compound 9 have insecticidal activities at 72h all greater than 40% ;

2)在化合物300mg/kg浓度下,化合物1、化合物4、化合物5、化合物6、化合物7、化合物9和化合物10均对玉米螟具有较好的杀虫活性,其中化合物1、化合物4、化合物9和化合物10在72h对玉米螟完全杀灭。2) Under the concentration of compound 300mg/kg, compound 1, compound 4, compound 5, compound 6, compound 7, compound 9 and compound 10 all have good insecticidal activity against corn borer, wherein compound 1, compound 4, compound 9 and compound 10 completely killed the corn borer at 72h.

实施例1-10所得的化合物对果蝇的杀虫活性测试Insecticidal activity test of the compounds obtained in Examples 1-10 on Drosophila

采用IRAC敏感性测试026号方法测试了10个化合物在100mg/L浓度下对果蝇的杀虫活性。The insecticidal activity of 10 compounds against Drosophila at a concentration of 100 mg/L was tested by IRAC Sensitivity Test No. 026 method.

1、试剂与材料:1. Reagents and materials:

①原药:化合物1-10①Technical drug: Compounds 1-10

②溶剂:DMSO(分析纯)②Solvent: DMSO (analytical grade)

③生物材料:果蝇成年雌虫③ Biological material: Drosophila adult females

2、实验方法2. Experimental method

1)配制100mg/L的待测化合物稀释液1) Prepare 100mg/L dilution of the compound to be tested

将供试化合物原药溶解在100μLDMSO中,配制成母液,用20%w/v蔗糖溶液将母液稀释为100mg/L的待测化合物稀释液,每种待测化合物稀释液约需要5mL,以添加相同量溶剂(DMSO)的20%蔗糖溶液作为对照组。Dissolve the original drug of the test compound in 100 μL DMSO, prepare a mother solution, and dilute the mother solution with 20% w/v sucrose solution to 100 mg/L of the test compound dilution, each test compound dilution needs about 5mL, to add A 20% sucrose solution in the same amount of solvent (DMSO) served as a control.

2)供试昆虫的筛选2) Screening of test insects

将选取的果蝇用二氧化碳麻醉后确定其性别,挑选生长一致且健康的成年雌虫作为待试昆虫。选取待试果蝇后,不应再受到外部环境(如高温、潮湿或饥饿)刺激的影响。The selected fruit flies were anesthetized with carbon dioxide to determine their sex, and adult females with consistent growth and healthy growth were selected as test insects. After selecting the flies to be tested, they should no longer be stimulated by the external environment (such as high temperature, humidity or starvation).

3)混药与接虫3) Mixing and receiving insects

将一片2cm的牙芯放置到175mL塑料容器中,用浓度为20%的蔗糖溶液(1.2mL)润湿处理,将其作为对照组。在另外相同容器内,用1.2mL含待测化合物的蔗糖溶液润湿牙芯,作为实验组。将10只大小均匀的雌性果蝇放置到每个容器中,用泡沫塞盖住容器。处理后将塑料容器转移至(23±2)℃、相对湿度50%和光周期L/D=12h/12h(光照、遮光分别处理12h)的条件下饲养。A piece of 2 cm dental core was placed in a 175 mL plastic container, and treated with a 20% concentration of sucrose solution (1.2 mL), which was used as a control group. In another identical container, the dental cores were wetted with 1.2 mL of the test compound-containing sucrose solution as the experimental group. Place 10 female flies of uniform size into each container and cover the container with a foam stopper. After treatment, the plastic container was transferred to (23±2)°C, relative humidity 50% and photoperiod L/D=12h/12h (light and shading were treated for 12h respectively).

4)检查与数据处理4) Inspection and data processing

经过48h后统计果蝇死亡数。每个待测药物重复3次实验,统计实验组和对照组果蝇死亡数,计算死亡率和校正死亡率。The number of dead flies was counted after 48 hours. The experiment was repeated three times for each drug to be tested, and the number of dead flies in the experimental group and the control group was counted, and the mortality and corrected mortality were calculated.

校正死亡率:P1=(Pt-P0)/(1-P0)*100%Corrected mortality: P 1 =(P t -P 0 )/(1-P 0 )*100%

式中,Pt代表实验组死亡率,P0代表对照组死亡率,P1代表校正死亡率。In the formula, P t represents the mortality rate of the experimental group, P 0 represents the mortality rate of the control group, and P 1 represents the corrected mortality rate.

3、实验结果3. Experimental results

化合物1-10在100mg/kg下对果蝇的杀虫活性见表3。The insecticidal activities of compounds 1-10 against Drosophila at 100 mg/kg are shown in Table 3.

表3:table 3:

死亡率(48h)(%±SEM)Mortality (48h) (%±SEM) 校正死亡率(48h)(%±SEM)Corrected mortality (48h) (%±SEM) 化合物1Compound 1 100.00±0.00100.00±0.00 100.00±0.00100.00±0.00 化合物2Compound 2 36.67±12.4736.67±12.47 33.70±16.4933.70±16.49 化合物3Compound 3 10.00±8.1610.00±8.16 10.00±8.1610.00±8.16 化合物4Compound 4 100.00±0.00100.00±0.00 100.00±0.00100.00±0.00 化合物5Compound 5 100.00±0.00100.00±0.00 100.00±0.00100.00±0.00 化合物6Compound 6 93.33±4.7193.33±4.71 92.96±5.0092.96±5.00 化合物7Compound 7 23.33±4.7123.33±4.71 20.74±1.0520.74±1.05 化合物8Compound 8 53.33±12.4753.33±12.47 51.11±14.9951.11±14.99 化合物9Compound 9 100.00±0.00100.00±0.00 100.00±0.00100.00±0.00 化合物10Compound 10 96.67±4.7196.67±4.71 96.30±5.2496.30±5.24

4、测试结果表明:在化合物100mg/L浓度下,化合物1-10均对果蝇具有较好的杀虫活性,其中化合物1、化合物4、化合物5、化合物6、化合物8、化合物9和化合物10均具有较高的杀虫活性,48h致死率均大于92%,其中化合物1、化合物4、化合物5和化合物9的48h致死率达到100%。4. The test results show that: at the concentration of compound 100mg/L, compound 1-10 has good insecticidal activity against Drosophila, among which compound 1, compound 4, compound 5, compound 6, compound 8, compound 9 and compound All 10 had high insecticidal activity, and the 48-hour lethality was greater than 92%, among which the 48-hour lethality of compound 1, compound 4, compound 5 and compound 9 reached 100%.

综上,本发明对应与通式I的含三氟甲烷异噁唑啉类衍生物对果蝇和斜纹夜蛾具有较好的杀虫活性,能够作为杀虫剂使用。To sum up, the isoxazoline derivatives containing trifluoromethane corresponding to the general formula I of the present invention have good insecticidal activity against Drosophila and Spodoptera litura, and can be used as insecticides.

以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the protection of the present invention. within the range.

Claims (10)

1.一种含三氟甲烷异噁唑啉类衍生物,其特征在于,其化学结构式如通式Ⅰ所示:1. a kind of isoxazoline derivatives containing trifluoromethane is characterized in that, its chemical structural formula is as shown in general formula I:
Figure FDA0003630191220000011
Figure FDA0003630191220000011
其中,R1a、R1b和R1c彼此独立的表示为氢原子和卤素原子中的任意一种,所述卤素原子表示为氯原子和氟原子中的任意一种;Wherein, R 1a , R 1b and R 1c are independently represented by any one of a hydrogen atom and a halogen atom, and the halogen atom is represented by any one of a chlorine atom and a fluorine atom; A表示为吡咯基和B中的任意一种,所述B表示为苯基、吡啶基和噻唑基中的任意一种;A represents any one of pyrrolyl and B, and said B represents any one of phenyl, pyridyl and thiazolyl; R2表示为氢原子和甲基中的任意一种;R 2 represents any one of a hydrogen atom and a methyl group; R3表示为-CH2C(O)NHCH2CF3、-OCH3、-CH2COOCH3和6-氯嘧啶基中的任意一种。R 3 represents any one of -CH 2 C(O)NHCH 2 CF 3 , -OCH 3 , -CH 2 COOCH 3 and 6-chloropyrimidinyl.
2.根据权利要求1所述的含三氟甲烷异噁唑啉类衍生物,其特征在于,所述含三氟甲烷异噁唑啉类衍生物包括通式I-1和通式I-2中任意一种所示的化合物:2. The trifluoromethane-containing isoxazoline derivative according to claim 1, wherein the trifluoromethane-containing isoxazoline derivative comprises general formula I-1 and general formula I-2 Any of the compounds shown in:
Figure FDA0003630191220000012
Figure FDA0003630191220000012
其中,R1a、R1b和R1c彼此独立的表示为氢原子和卤素原子中的任意一种,所述卤素原子表示为氯原子和氟原子中的任意一种;Wherein, R 1a , R 1b and R 1c are independently represented by any one of a hydrogen atom and a halogen atom, and the halogen atom is represented by any one of a chlorine atom and a fluorine atom; B表示为苯基、吡啶基和噻唑基中的任意一种;B represents any one of phenyl, pyridyl and thiazolyl; R2表示为氢原子和甲基中的任意一种;R 2 represents any one of a hydrogen atom and a methyl group; R3表示为-CH2C(O)NHCH2CF3、-OCH3、-CH2COOCH3和6-氯嘧啶基中的任意一种。R 3 represents any one of -CH 2 C(O)NHCH 2 CF 3 , -OCH 3 , -CH 2 COOCH 3 and 6-chloropyrimidinyl.
3.根据权利要求1或2所述的含三氟甲烷异噁唑啉类衍生物,其特征在于,所述含三氟甲烷异噁唑啉类衍生物包括如下具体结构式中的任意一种:3. The trifluoromethane-containing isoxazoline derivative according to claim 1 or 2, wherein the trifluoromethane-containing isoxazoline derivative comprises any one of the following specific structural formulas:
Figure FDA0003630191220000021
Figure FDA0003630191220000021
Figure FDA0003630191220000031
Figure FDA0003630191220000031
4.权利要求1-3任一项所述的含三氟甲烷异噁唑啉类衍生物的制备方法,其特征在于,反应式如下:4. the preparation method containing trifluoromethane isoxazoline derivatives described in any one of claim 1-3, is characterized in that, reaction formula is as follows:
Figure FDA0003630191220000032
Figure FDA0003630191220000032
Figure FDA0003630191220000041
Figure FDA0003630191220000041
Figure FDA0003630191220000051
Figure FDA0003630191220000051
Figure FDA0003630191220000061
Figure FDA0003630191220000061
其中,R1a、R1b和R1c彼此独立的表示为氢原子和卤素原子中的任意一种;wherein, R 1a , R 1b and R 1c are independently represented by any one of hydrogen atoms and halogen atoms; B表示为苯基、吡啶基和噻唑基中的任意一种;B represents any one of phenyl, pyridyl and thiazolyl; R2表示为氢原子和甲基中的任意一种;R 2 represents any one of a hydrogen atom and a methyl group; R3表示为-CH2C(O)NHCH2CF3、-OCH3、-CH2COOCH3和6-氯嘧啶基中的任意一种;R 3 represents any one of -CH 2 C(O)NHCH 2 CF 3 , -OCH 3 , -CH 2 COOCH 3 and 6-chloropyrimidinyl; R4、R5彼此独立的表示为甲基和乙基中的任意一种;R 4 and R 5 are independently represented by any one of methyl and ethyl; 制备包括以下步骤:Preparation includes the following steps: 步骤A:如反应式一所示,将化合物a、卤代-三氟-烯烃、催化剂和碱在溶剂中进行反应,制得中间体a;Step A: As shown in reaction formula 1, compound a, halogenated-trifluoro-alkene, catalyst and base are reacted in a solvent to obtain intermediate a; 步骤B:如反应式二所示,将化合物b与氰化亚铜在DMF中反应,得到中间体b1;将中间体b1、盐酸羟胺与醋酸钠在乙醇中反应,得到中间体c;将中间体c、亚硝酸钠和质量浓度11.5%的盐酸反应,得到中间体d1;Step B: as shown in reaction formula 2, react compound b with cuprous cyanide in DMF to obtain intermediate b1; react intermediate b1, hydroxylamine hydrochloride and sodium acetate in ethanol to obtain intermediate c; Body c, sodium nitrite and hydrochloric acid with a mass concentration of 11.5% are reacted to obtain intermediate d1; 或将化合物c、N,N-二甲基甲酰胺和三氯氧磷在二氯甲烷中反应,得到中间体b2;将中间体b2与盐酸羟胺与醋酸钠在乙醇中反应,得到中间体d2;Or react compound c, N,N-dimethylformamide and phosphorus oxychloride in dichloromethane to obtain intermediate b2; react intermediate b2 with hydroxylamine hydrochloride and sodium acetate in ethanol to obtain intermediate d2 ; 步骤C:如反应式三所示,将步骤A的中间体a、步骤B的中间体d1和TEA在DMF中反应,得到中间体e1;Step C: As shown in reaction formula 3, the intermediate a of step A, the intermediate d1 of step B and TEA are reacted in DMF to obtain intermediate e1; 或将步骤A的中间体a、步骤B的中间体d2、氯化钾和过硫酸钾在甲醇中反应,得到中间体e2;Or react the intermediate a of step A, the intermediate d2 of step B, potassium chloride and potassium persulfate in methanol to obtain intermediate e2; 步骤D:如反应式四所示,将中间体e1和氢氧化钠在乙醇中反应,得到中间体f1;将中间体f1、DPPA、TEA和R3-NH2在DMF中反应,得到通式I-1所示的化合物;Step D: as shown in reaction formula 4, the intermediate e1 and sodium hydroxide are reacted in ethanol to obtain the intermediate f1; the intermediate f1, DPPA, TEA and R 3 -NH 2 are reacted in DMF to obtain the general formula The compound shown in I-1; 或将中间体e2和氢氧化钠在乙醇中反应,得到中间体f2;将中间体f2、DPPA、TEA和R3-NH2在DMF中反应,得到通式I-2所示的化合物,通式I-1所示的化合物和通式I-2所示的化合物均为含三氟甲烷异噁唑啉类衍生物。Or react intermediate e2 and sodium hydroxide in ethanol to obtain intermediate f2; react intermediate f2, DPPA, TEA and R 3 -NH 2 in DMF to obtain a compound represented by general formula I-2, which is generally The compound represented by the formula I-1 and the compound represented by the general formula I-2 are both trifluoromethane-containing isoxazoline derivatives.
5.根据权利要求4所述的制备方法,其特征在于,步骤A中,所述化合物a、所述卤代-三氟-烯烃、所述催化剂和所述碱反应的摩尔比为1:(1.2~2.0):(0.015~0.03):(1.1~1.5),所述反应的温度为80~90℃,反应时间3~5h;5. preparation method according to claim 4 is characterized in that, in step A, the mol ratio of described compound a, described halogenated-trifluoro-alkene, described catalyst and described alkali reaction is 1: ( 1.2~2.0): (0.015~0.03): (1.1~1.5), the temperature of the reaction is 80~90℃, and the reaction time is 3~5h; 所述卤代-三氟-烯烃为2-溴-3,3,3-三氟-1-丙烯;The halogenated-trifluoro-alkene is 2-bromo-3,3,3-trifluoro-1-propene; 所述溶剂为四氢呋喃、1,4-二氧六环、N,N二甲基甲酰胺、四氢呋喃和水中的任意一种或多种;The solvent is any one or more of tetrahydrofuran, 1,4-dioxane, N,N dimethylformamide, tetrahydrofuran and water; 所述催化剂为四(三苯基膦)钯和双(三苯基膦)二氯化钯中的任意一种;Described catalyst is any one in tetrakis (triphenylphosphine) palladium and bis (triphenylphosphine) palladium dichloride; 所述碱为碳酸钠、碳酸钾和碳酸铯中的任意一种。The alkali is any one of sodium carbonate, potassium carbonate and cesium carbonate. 6.根据权利要求4所述的制备方法,其特征在于,步骤B中,所述化合物b与所述氰化亚铜的摩尔比为1:(1.5~3.0),所述反应的温度为140~170℃,反应时间为2~8h;The preparation method according to claim 4, characterized in that, in step B, the molar ratio of the compound b to the cuprous cyanide is 1:(1.5~3.0), and the reaction temperature is 140 ~170℃, the reaction time is 2~8h; 所述中间体b1、所述盐酸羟胺和所述醋酸钠的摩尔比为1:(1.1~1.5):(1.1~1.5),所述反应的温度为70~90℃,反应时间为1~4.5h;The molar ratio of the intermediate b1, the hydroxylamine hydrochloride and the sodium acetate is 1:(1.1-1.5):(1.1-1.5), the reaction temperature is 70-90°C, and the reaction time is 1-4.5 h; 所述中间体b2、所述盐酸羟胺和所述醋酸钠的摩尔比为1:(1.1~1.5):(1.1~1.5),所述反应的温度为70~90℃,反应时间为1~4.5h。The molar ratio of the intermediate b2, the hydroxylamine hydrochloride and the sodium acetate is 1:(1.1-1.5):(1.1-1.5), the reaction temperature is 70-90°C, and the reaction time is 1-4.5 h. 7.根据权利要求4所述的制备方法,其特征在于,步骤C中,所述中间体a与所述中间体d1的摩尔比为1:(1.1~1.8),所述反应的温度为50~70℃,反应时间6~12h。7. The preparation method according to claim 4, wherein in step C, the molar ratio of the intermediate a to the intermediate d1 is 1:(1.1-1.8), and the reaction temperature is 50 ℃ ~70℃, the reaction time is 6~12h. 8.根据权利要求4所述的制备方法,其特征在于,步骤D中,所述中间体f1、所述DPPA、所述TEA和所述R3-NH2的摩尔比为1:(1.0~1.8):(0.2~0.5):(1.0~1.8),所述反应的温度为0℃或25~35℃,反应时间10~20h;The preparation method according to claim 4, wherein in step D, the molar ratio of the intermediate f1, the DPPA, the TEA and the R 3 -NH 2 is 1:(1.0~ 1.8): (0.2~0.5): (1.0~1.8), the temperature of the reaction is 0°C or 25~35°C, and the reaction time is 10~20h; 所述中间体f2、所述DPPA、所述TEA和所述R3-NH2的摩尔比为1:(1.0~1.8):(0.2~0.5):(1.0~1.8),所述反应的温度为0℃或25~35℃,反应时间10~20h。The molar ratio of the intermediate f2, the DPPA, the TEA and the R 3 -NH 2 is 1:(1.0-1.8):(0.2-0.5):(1.0-1.8), and the reaction temperature It is 0℃ or 25~35℃, and the reaction time is 10~20h. 9.权利要求1-3任一项所述的含三氟甲烷异噁唑啉类衍生物,或其农药学可接受的盐在制备杀虫剂中的应用。9. Use of the trifluoromethane-containing isoxazoline derivative according to any one of claims 1 to 3, or a pesticide acceptable salt thereof, in the preparation of pesticides. 10.根据权利要求9所述的应用,其特征在于,所述杀虫剂包括权利要求1-3任一项所述的含三氟甲烷异噁唑啉类衍生物,或其农药学可接受的盐,以及至少一种农药学可接受的赋型剂。10. The application according to claim 9, wherein the pesticide comprises the trifluoromethane-containing isoxazoline derivative according to any one of claims 1-3, or its pesticide acceptable and at least one pesticidally acceptable excipient.
CN202210488398.2A 2022-05-06 2022-05-06 Trifluoromethyl-containing isoxazoline derivative, and preparation method and application thereof Pending CN114853748A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210488398.2A CN114853748A (en) 2022-05-06 2022-05-06 Trifluoromethyl-containing isoxazoline derivative, and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210488398.2A CN114853748A (en) 2022-05-06 2022-05-06 Trifluoromethyl-containing isoxazoline derivative, and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN114853748A true CN114853748A (en) 2022-08-05

Family

ID=82634856

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210488398.2A Pending CN114853748A (en) 2022-05-06 2022-05-06 Trifluoromethyl-containing isoxazoline derivative, and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114853748A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116283946A (en) * 2023-03-27 2023-06-23 武汉工程大学 5- (N-substituted indole-5-yl) isoxazole-3-formic acid derivative and synthetic method and application thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1930136A (en) * 2004-03-05 2007-03-14 日产化学工业株式会社 Isoxazoline-substituted benzamide compound and noxious organism control agent
CN102256971A (en) * 2008-12-19 2011-11-23 诺瓦提斯公司 Isoxazoline derivatives and their use as pesticide
CN103347880A (en) * 2011-02-10 2013-10-09 诺瓦提斯公司 Isoxazoline derivatives for controlling invertebrate pests
CN111393415A (en) * 2020-04-30 2020-07-10 苏州信诺维医药科技有限公司 Heteroaromatic nitrile compound and application thereof
CN112552252A (en) * 2020-09-30 2021-03-26 浙江美诺华药物化学有限公司 Preparation method of flurarana intermediate
CN112574230A (en) * 2019-09-27 2021-03-30 南京药捷安康生物科技有限公司 Peptidyl arginine deiminase inhibitors and uses thereof
CN113773312A (en) * 2021-09-08 2021-12-10 河南牧业经济学院 Novel isoxazoline derivative and preparation method and application thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1930136A (en) * 2004-03-05 2007-03-14 日产化学工业株式会社 Isoxazoline-substituted benzamide compound and noxious organism control agent
CN101768129A (en) * 2004-03-05 2010-07-07 日产化学工业株式会社 Production intermediate of isoxazoline-substituted benzamide compound
CN102256971A (en) * 2008-12-19 2011-11-23 诺瓦提斯公司 Isoxazoline derivatives and their use as pesticide
CN103347880A (en) * 2011-02-10 2013-10-09 诺瓦提斯公司 Isoxazoline derivatives for controlling invertebrate pests
CN112574230A (en) * 2019-09-27 2021-03-30 南京药捷安康生物科技有限公司 Peptidyl arginine deiminase inhibitors and uses thereof
CN111393415A (en) * 2020-04-30 2020-07-10 苏州信诺维医药科技有限公司 Heteroaromatic nitrile compound and application thereof
CN112552252A (en) * 2020-09-30 2021-03-26 浙江美诺华药物化学有限公司 Preparation method of flurarana intermediate
CN113773312A (en) * 2021-09-08 2021-12-10 河南牧业经济学院 Novel isoxazoline derivative and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"RN 930108-32-0" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116283946A (en) * 2023-03-27 2023-06-23 武汉工程大学 5- (N-substituted indole-5-yl) isoxazole-3-formic acid derivative and synthetic method and application thereof
CN116283946B (en) * 2023-03-27 2024-05-07 武汉工程大学 5- (N-substituted indole-5-yl) isoxazole-3-formic acid derivative and synthetic method and application thereof

Similar Documents

Publication Publication Date Title
BRPI0914217B1 (en) 1-SUBSTITUTED PYRIDYL-PYRAZOLYL AMID COMPOUNDS AND THE USES THEREOF
CN102933563A (en) Substituted 3,5-di phenyl-isoxazoline derivatives as insecticides and acaricides
CN103467380B (en) Substituted phenyl pyrazole amide derivative and preparation method and application thereof
CN101935291A (en) A cyano-containing phthalamide compound, preparation method and use as an agrochemical insecticide
CN101558758A (en) L-alpha-amino acid ester contained Z-configuration anabasine pesticide and preparation method thereof
CN114853748A (en) Trifluoromethyl-containing isoxazoline derivative, and preparation method and application thereof
CN108341808B (en) A kind of oxadiazole dipyrazole compound and use thereof
CN112624993B (en) Nitrogen-containing heterocyclic structure oxazoline derivatives and their preparation and application in controlling phytophagous mites
TW202452B (en)
CN102391249A (en) 3,5-dichloropyridyl pyrazole amide compound and application thereof
CN104725276B (en) Heptafluoroisopropyl-containing carbonyl oxime ether compound, preparation method and applications thereof
CN103420975B (en) Fluorine-contained o-amino thiobenzamide type compound and application thereof
CN102617397B (en) Ortho-formyl aminobenzoyl hydrazide compound, preparation method thereof and application
CN114380762A (en) Isoxazoline hydrazide derivative and preparation method and application thereof
PT95241B (en) 13-ALKYL-23-IMINO AND 13-HALO-23-IMINO COMPOUND LL-F28249 DERIVATIVES, UTEIS AS ENDO-E ECTOPARIASITICID AGENTS
JPH02145A (en) Glutamic acid receptor inhibitor, production thereof and insecticidal composition
CN114933597B (en) 3-hydroxyisothiazoline derivative, preparation method and application
CN102225933B (en) 2, 6-dimethyl-3, 5-bis[3-(5- trifluoromethyl)-1H- pyrazole] pyridine and synthesis method thereof
CN104557691B (en) A kind of 3 amine acyl bishydrazide derivatives and its preparation method and application
JPS59116243A (en) 2-arylethyl ether derivative and thioether derivative, their preparations and insecticide and acaricide
KR840001051B1 (en) Method for preparing benzimidazoline salt
CN111187214B (en) Fluorobenzene bishydrazide azole compound and application thereof
JP3650206B2 (en) Antifungal agent
JPS63156765A (en) Benzoyl urea compounds and insecticides and acaricides containing them as active ingredients
CN106632132A (en) High-activity N-alkoxy neonicotinoid analogues as well as preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20220805

RJ01 Rejection of invention patent application after publication